Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CAMPBELL'S CoCPB · Entity 3700 | Senior Vice President | September 30, 2016 | October 04, 2016 |
| HERBALIFE LTD.HLF · Entity 4842 | Director | May 09, 2019 | May 13, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CAMPBELL'S Co
Report date September 30, 2016 · Filed October 04, 2016
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 41,852 |
Ending reported balance
After 2016-09-30 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2016-09-30 · Disposition to issuer · Disposed 58,172 · Balance 54,603 F1: Represents number of shares previously reported as acquired by the reporting person that were forfeited because the performance criteria required for vesting were not met. Row 2 · 2016-09-30 · Tax withholding · Disposed 12,751 · Balance 41,852 |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $54.65 · Expires 2016-10-01 | Direct | 48,828 |
Reported balance
After 2016-10-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2016-10-01 · Grant · Acquired 48,828 · Balance 48,828 F2: The options will vest in equal installments on each of the first three anniversaries of the Grant Date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents number of shares previously reported as acquired by the reporting person that were forfeited because the performance criteria required for vesting were not met.
F2: The options will vest in equal installments on each of the first three anniversaries of the Grant Date.
HERBALIFE LTD.
Report date May 09, 2019 · Filed May 13, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 62,135 |
Ending reported balance
After 2019-05-09 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2019-05-09 · Exercise / conversion · Acquired 15,006 · Balance 69,069 F1: The Reporting Person received 8,072 shares of common stock upon the net exercise of 15,006 stock appreciation rights ("SARS"). The Reporting Person forfeited 6,934 shares of common stock underlying the SARS in payment of the exercise price, using the closing stock price on May 9, 2019 of $48.47. The Reporting Person did not sell any shares received from this net exercise of SARS. Row 2 · 2019-05-09 · Tax withholding · Disposed 6,934 · Balance 62,135 F1: The Reporting Person received 8,072 shares of common stock upon the net exercise of 15,006 stock appreciation rights ("SARS"). The Reporting Person forfeited 6,934 shares of common stock underlying the SARS in payment of the exercise price, using the closing stock price on May 9, 2019 of $48.47. The Reporting Person did not sell any shares received from this net exercise of SARS. |
| Stock Appreciation RightsSEC Table II · derivative / convertible security · Conversion / exercise price $22.40 · Expires 2019-05-31 | Direct | 0 |
Reported balance
After 2019-05-09 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-05-09 · Exercise / conversion · Disposed 15,006 · Balance 0 F1: The Reporting Person received 8,072 shares of common stock upon the net exercise of 15,006 stock appreciation rights ("SARS"). The Reporting Person forfeited 6,934 shares of common stock underlying the SARS in payment of the exercise price, using the closing stock price on May 9, 2019 of $48.47. The Reporting Person did not sell any shares received from this net exercise of SARS. F2: These SARS were previously reported as covering 7,503 shares at an exercise price of $44.79 per share, but were adjusted to reflect the stock split that occurred on May 14, 2018. F3: These SARs vested 25% on each of July 25, 2012, October 15, 2012, January 15, 2013 and April 15, 2013. |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting Person received 8,072 shares of common stock upon the net exercise of 15,006 stock appreciation rights ("SARS"). The Reporting Person forfeited 6,934 shares of common stock underlying the SARS in payment of the exercise price, using the closing stock price on May 9, 2019 of $48.47. The Reporting Person did not sell any shares received from this net exercise of SARS.
F2: These SARS were previously reported as covering 7,503 shares at an exercise price of $44.79 per share, but were adjusted to reflect the stock split that occurred on May 14, 2018.
F3: These SARs vested 25% on each of July 25, 2012, October 15, 2012, January 15, 2013 and April 15, 2013.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 09, 2019 Filed May 13, 2019 20:57 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionStock Appreciation Rights · Derivative | 15,006 | $0.00 Strike: $22.40 | $0.00 |
DisclosureSEC source: 0001209191-19-029374 · doc4.xml · derivative · entry 3 Dunn Jeff · CIK 0001476192 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,006 shares Expires 2019-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Reporting Person received 8,072 shares of common stock upon the net exercise of 15,006 stock appreciation rights ("SARS"). The Reporting Person forfeited 6,934 shares of common stock underlying the SARS in payment of the exercise price, using the closing stock price on May 9, 2019 of $48.47. The Reporting Person did not sell any shares received from this net exercise of SARS. F2 · shares: These SARS were previously reported as covering 7,503 shares at an exercise price of $44.79 per share, but were adjusted to reflect the stock split that occurred on May 14, 2018. F3 · derivative.exercise_date: These SARs vested 25% on each of July 25, 2012, October 15, 2012, January 15, 2013 and April 15, 2013. Read SEC document |
| May 09, 2019 Filed May 13, 2019 20:57 UTC | HERBALIFE LTD. HLF · Entity 4842 | Tax withholdingCommon Stock | 6,934 | $48.47 | $336,090.98 |
DisclosureSEC source: 0001209191-19-029374 · doc4.xml · nonDerivative · entry 2 Dunn Jeff · CIK 0001476192 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,135 F1 · shares: The Reporting Person received 8,072 shares of common stock upon the net exercise of 15,006 stock appreciation rights ("SARS"). The Reporting Person forfeited 6,934 shares of common stock underlying the SARS in payment of the exercise price, using the closing stock price on May 9, 2019 of $48.47. The Reporting Person did not sell any shares received from this net exercise of SARS. Read SEC document |
| May 09, 2019 Filed May 13, 2019 20:57 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionCommon Stock | 15,006 | $22.40 | $336,059.37 |
DisclosureSEC source: 0001209191-19-029374 · doc4.xml · nonDerivative · entry 1 Dunn Jeff · CIK 0001476192 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,069 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Reporting Person received 8,072 shares of common stock upon the net exercise of 15,006 stock appreciation rights ("SARS"). The Reporting Person forfeited 6,934 shares of common stock underlying the SARS in payment of the exercise price, using the closing stock price on May 9, 2019 of $48.47. The Reporting Person did not sell any shares received from this net exercise of SARS. Read SEC document |
| May 06, 2019 Filed May 8, 2019 23:21 UTC | HERBALIFE LTD. HLF · Entity 4842 | GrantCommon Stock | 3,187 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-028355 · doc4.xml · nonDerivative · entry 1 Dunn Jeff · CIK 0001476192 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,063 F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2014 Stock Incentive Plan. The RSUs will vest 100% on April 15, 2020, subject to continued service on the Issuer's Board of Directors through such date. F2 · balance_after: Amount reflected corrects the balance due to prior administrative error. Read SEC document |
| August 03, 2018 Filed Aug 6, 2018 20:17 UTC | HERBALIFE LTD. HLF · Entity 4842 | SaleCommon Stock | 17,440 | $58.53 | $1,020,763.20 |
DisclosureSEC source: 0001209191-18-045517 · doc4.xml · nonDerivative · entry 1 Dunn Jeff · CIK 0001476192 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,076 F1 · balance_after: On May 14, 2018, the common stock of Herbalife Nutrition Ltd. split 2-for-1, resulting in the reporting person's acquisition of 33,258 additional shares of common stock. Read SEC document |
| May 07, 2018 Filed May 9, 2018 21:07 UTC | HERBALIFE LTD. HLF · Entity 4842 | GrantCommon Stock | 1,416 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-028906 · doc4.xml · nonDerivative · entry 1 Dunn Jeff · CIK 0001476192 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,258 F1 · kind: Consists of restricted stock units ("RSU") under the Herbalife Nutrition Ltd. 2014 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of Herbalife Nutrition Ltd. common stock on vesting. This award includes 221 RSUs representing the 2018 lead director. This award will vest 100% on April 15, 2019. Read SEC document |
| April 16, 2018 Filed Apr 18, 2018 20:24 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionStock Appreciation Rights · Derivative | 5,452 | $0.00 Strike: $53.29 | $0.00 |
DisclosureSEC source: 0001209191-18-025367 · doc4.xml · derivative · entry 3 Dunn Jeff · CIK 0001476192 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,452 shares Expires 2018-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reporting person received 2,588 shares of common stock upon the net exercise of the 5,452 stock appreciation rights ("SARs"). The reporting person forfeited 2,864 shares of common stock underlying SARs in payment of the exercise price using the closing stock price on April 16, 2018 of $101.46 Read SEC document |
| April 16, 2018 Filed Apr 18, 2018 20:24 UTC | HERBALIFE LTD. HLF · Entity 4842 | Disposition to issuerCommon Stock | 2,864 | $101.46 | $290,581.44 |
DisclosureSEC source: 0001209191-18-025367 · doc4.xml · nonDerivative · entry 2 Dunn Jeff · CIK 0001476192 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,842 F1 · kind: The reporting person received 2,588 shares of common stock upon the net exercise of the 5,452 stock appreciation rights ("SARs"). The reporting person forfeited 2,864 shares of common stock underlying SARs in payment of the exercise price using the closing stock price on April 16, 2018 of $101.46 Read SEC document |
| April 16, 2018 Filed Apr 18, 2018 20:24 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionCommon Stock | 5,452 | $53.29 | $290,537.08 |
DisclosureSEC source: 0001209191-18-025367 · doc4.xml · nonDerivative · entry 1 Dunn Jeff · CIK 0001476192 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,706 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reporting person received 2,588 shares of common stock upon the net exercise of the 5,452 stock appreciation rights ("SARs"). The reporting person forfeited 2,864 shares of common stock underlying SARs in payment of the exercise price using the closing stock price on April 16, 2018 of $101.46 Read SEC document |
| May 08, 2017 Filed May 10, 2017 00:28 UTC | HERBALIFE LTD. HLF · Entity 4842 | GrantCommon Stock | 1,665 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-031102 · doc4.xml · nonDerivative · entry 1 Dunn Jeff · CIK 0001476192 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,254 F1 · kind: Consists of restricted stock units under the Herbalife Ltd. 2014 Stock Incentive Plan. This award will vest 100% on April 15, 2018. Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 00:16 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionStock Appreciation Rights · Derivative | 13,064 | $0.00 Strike: $22.94 | $0.00 |
DisclosureSEC source: 0001209191-17-018508 · doc4.xml · derivative · entry 3 Dunn Jeff · CIK 0001476192 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,064 shares Expires 2017-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 00:16 UTC | HERBALIFE LTD. HLF · Entity 4842 | Disposition to issuerCommon Stock | 5,353 | $55.99 | $299,714.47 |
DisclosureSEC source: 0001209191-17-018508 · doc4.xml · nonDerivative · entry 2 Dunn Jeff · CIK 0001476192 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,589 F1 · kind: The reporting person received 7,711 shares of common stock upon the net exercise of the 13,064 stock appreciation rights ("SARS"). The reporting person forfeited 5,353 shares of common stock underlying the SARS in payment of the exercise price, using the closing stock price on March 3, 2017 of $55.99. Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 00:16 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionCommon Stock | 13,064 | $22.94 | $299,688.16 |
DisclosureSEC source: 0001209191-17-018508 · doc4.xml · nonDerivative · entry 1 Dunn Jeff · CIK 0001476192 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,942 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2016 Filed Oct 4, 2016 19:45 UTC | CAMPBELL'S Co CPB · Entity 3700 | GrantEmployee Stock Option (right to buy) · Derivative | 48,828 | $0.00 Strike: $54.65 | $0.00 |
DisclosureSEC source: 0000016732-16-000156 · wf-form4_147561032400122.xml · derivative · entry 3 Dunn Jeff · CIK 0001476192 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,828 Underlying: Common Stock · 48,828 shares Expires 2016-10-01 F2 · derivative.exercise_date: The options will vest in equal installments on each of the first three anniversaries of the Grant Date. Read SEC document |
| September 30, 2016 Filed Oct 4, 2016 19:45 UTC | CAMPBELL'S Co CPB · Entity 3700 | Tax withholdingCommon Stock | 12,751 | $54.38 | $693,399.38 |
DisclosureSEC source: 0000016732-16-000156 · wf-form4_147561032400122.xml · nonDerivative · entry 2 Dunn Jeff · CIK 0001476192 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,852 Read SEC document |
| September 30, 2016 Filed Oct 4, 2016 19:45 UTC | CAMPBELL'S Co CPB · Entity 3700 | Disposition to issuerCommon Stock | 58,172 | $0.00 | $0.00 |
DisclosureSEC source: 0000016732-16-000156 · wf-form4_147561032400122.xml · nonDerivative · entry 1 Dunn Jeff · CIK 0001476192 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,603 F1 · shares: Represents number of shares previously reported as acquired by the reporting person that were forfeited because the performance criteria required for vesting were not met. Read SEC document |
| September 08, 2016 Filed Sep 9, 2016 15:57 UTC | CAMPBELL'S Co CPB · Entity 3700 | SaleCommon Stock | 8,459 | $56.24 | $475,734.16 |
DisclosureSEC source: 0000016732-16-000140 · wf-form4_147343663973767.xml · nonDerivative · entry 1 Dunn Jeff · CIK 0001476192 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,775 F1 · price: The price reflects the weighted average sale price for the transactions reported on this line. The range of prices for the transactions reported on this line were $56.24 to and including $56.25. The reporting person undertakes to provide the issuer, any security holder of the issuer or the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.